BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, June 6, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 19, 2021
View Archived Issues
Bionomics enters MoU with EmpathBio to explore combination of BNC-210 and EMP-01 for PTSD
Read More
MK-6482 show promising activity in ccRCC both as monotherapy and in combination with cabozantinib
Read More
Phase I/II results presented for GT-005 in geographic atrophy
Read More
BITT and BeiGene enter option and license agreement for TNFR2 antagonists
Read More
Ultimovacs begins phase I study of TET-based vaccine for prostate cancer
Read More
Immunotherapy targeting AT1R ameliorates experimental insulin resistance
Read More
Oneness submits IND in U.S. for phase II study of FB-704A in severe asthma
Read More
Positive topline data from investigator-sponsored phase II study of IMU-838 in PSC
Read More
Phase II study of KHK-4083 in atopic dermatitis meets primary endpoint
Read More
Flexion advances FX-201 into high-dose cohort of phase I study in patients with knee osteoarthritis
Read More
Phase II study of Thykamine in atopic dermatitis meets its primary endpoint
Read More
Hoth plans to expand development of HT-003 for inflammatory bowel diseases
Read More
Enrollment ongoing in phase I study of TNB-486 in relapsed or refractory B-NHL
Read More
Rucaparib demonstrates promising activity in BAP1-negative or BRCA1-negative mesothelioma
Read More
PRMT5 as promising therapeutic target for glioblastoma
Read More
Bettering bile: New organoid marks progress to liver repair beyond hepatocytes
Read More
Phase II trial of imaging agent [64Cu]SARTATE enrolls patients with known or suspected NETs
Read More
AAV-mediated gene therapy FLT-201 shows robust potency for treating Gaucher disease
Read More
Rocket begins phase I study of RP-L401 in infantile malignant osteopetrosis
Read More
Orinove initiates phase Ib trial of oral ORIN-1001 in IPF
Read More
Dopamine progenitor cell product MSK-DA01 ameliorates Parkinsonian deficits in animal model
Read More
CHI3L1 is a risk marker for delirium in older patients undergoing surgery
Read More
Zebrafish used to model perivascular glioblastoma multiforme invasion
Read More
